These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11495231)
1. Meningococcal disease--management of serogroup C clusters in a hyperendemic area. Dell E; Bedford D; McMahon B; Nicholson A Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231 [TBL] [Abstract][Full Text] [Related]
2. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern]. de Mateo Ontañón S Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848 [TBL] [Abstract][Full Text] [Related]
3. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Krízová P; Musílek M; Kalmusová J Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424 [TBL] [Abstract][Full Text] [Related]
4. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China. Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129 [TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Krizova P; Musilek M Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519 [TBL] [Abstract][Full Text] [Related]
6. The changing epidemiology of meningococcal disease in the United States, 1992-1996. Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946 [TBL] [Abstract][Full Text] [Related]
7. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination]. Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849 [TBL] [Abstract][Full Text] [Related]
8. Global epidemiology of meningococcal disease. Harrison LH; Trotter CL; Ramsay ME Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562 [TBL] [Abstract][Full Text] [Related]
9. Meningococcal disease in the Republic of Ireland: 1995. Fogarty I; Cafferkey MT; Moloney AC Commun Dis Rep CDR Rev; 1997 Jan; 7(1):R9-13. PubMed ID: 9029872 [TBL] [Abstract][Full Text] [Related]
10. Meningococcal disease due to serogroup Y in Scotland, 1992-1999. Clarke SC; Reid J; Thom L; Denham BC; Edwards GF Br J Biomed Sci; 2001; 58(1):17-9. PubMed ID: 11284218 [TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction for diagnosis and serogrouping of meningococcal disease in children. Munoz-Almagro C; Rodriguez-Plata MT; Marin S; Esteva C; Esteban E; Gene A; Gelabert G; Jordan I Diagn Microbiol Infect Dis; 2009 Feb; 63(2):148-54. PubMed ID: 19026504 [TBL] [Abstract][Full Text] [Related]
12. Influence of age on serogroup distribution of endemic meningococcal disease. Baker CJ; Griffiss JM Pediatrics; 1983 Jun; 71(6):923-6. PubMed ID: 6406978 [TBL] [Abstract][Full Text] [Related]
13. Serogroup B meningococcal disease--Oregon, 1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1995 Feb; 44(7):121-4. PubMed ID: 7845348 [TBL] [Abstract][Full Text] [Related]
14. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756 [TBL] [Abstract][Full Text] [Related]
15. Meningococcal disease in Auckland, July 1992 - June 1994. Jefferies C; Lennon D; Stewart J; Martin D N Z Med J; 1999 Apr; 112(1085):115-7. PubMed ID: 10326799 [TBL] [Abstract][Full Text] [Related]
16. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients]. de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001. Tsang RS; Squires SG; Tam TW Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497 [TBL] [Abstract][Full Text] [Related]
18. Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board. Shahdadpuri RI; Nicholson AJ; Bedford D; O'Flanagan D Ir Med J; 2004 Feb; 97(2):44-6. PubMed ID: 15134268 [TBL] [Abstract][Full Text] [Related]
19. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Brooks R; Woods CW; Benjamin DK; Rosenstein NE Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417 [TBL] [Abstract][Full Text] [Related]
20. [Increased incidence of invasive meningococcal disease caused by C:2a:P1.2 meningococci in certain regions of the Czech Republic]. Krízová-Kuzemenská P; Benes C; Dlhy J; Kartusek S; Matuska J; Vlcková J; Galetková A; Roznovský L Cesk Epidemiol Mikrobiol Imunol; 1993 Dec; 42(4):165-71. PubMed ID: 8306396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]